1 Here,
we describe a combined biological/enzymatic synthesis that is
2 Here,
we describe a generalizable platform to create dual-FP biosen
3 In summary,
we describe a mechanism by which increased cytosolic Ca(2+) n
4 Here
we describe a molecular system that can be programmed to cont
5 Here,
we describe a mouse strain lacking the E3 ubiquitin ligase RN
6 Here
we describe a new, exquisitely three-dimensionally preserved
7 Finally,
we describe a novel form of activity-dependent intrinsic plas
8 We describe a novel method of kinetic analysis of radioligand
9 Here,
we describe a rapid, inexpensive, and portable strategy to ro
10 Herein,
we describe a simple, selective, and mild procedure for the c
11 Here,
we describe a structure we refer to as the embryo sheath that
12 Lastly,
we describe an analogous Foxa2+ population during differentia
13 In this work,
we describe an electronics-based Enzyme-Linked ImmunoSorbent
14 Here
we describe an enhanced fluorescence fluctuation imaging anal
15 We describe an intriguing tension between phenotypic complexi
16 To improve computational efficiency,
we describe an new importance sampling scheme to perform mode
17 Here
we describe an update of the database.
18 In this study,
we describe and characterize novel sensors based on the Syste
19 Here
we described and analyzed a similar phenotype in POMT mutant
20 In this study,
we describe data indicating that the yeast family members Ltc
21 Here
we describe DeActs, genetically encoded actin-modifying polyp
22 In the present study,
we describe for the first time the presence of ACSL6 mRNA in
23 We describe here a serum-free, artificial thymic organoid (AT
24 We describe here important differences in how the Rb and p107
25 ured in any system through mechanisms similar to those that
we describe here.
26 We describe herein its structure and replicative cycle, along
27 In this paper
we describe HistomicsML, an interactive machine-learning syst
28 Here,
we describe how F-specific antibodies protect against RSV and
29 As an example,
we describe how this method can be used to covalently immobil
30 In this first part of a 2-part review,
we describe indications, implant-related complications, basic
31 Here,
we describe mGluR5 findings in stress disorders, particularly
32 Here, using a palette of histological methods
we describe neurons and their neuropils most immediately asso
33 We describe new mechanisms of coding and noncoding alteration
34 We describe opportunities and challenges in RNA structural mo
35 In this study,
we describe population-level trends in the adult life expecta
36 In this update,
we describe recent changes and additions to our website, data
37 Here
we describe ShootingStar, a platform for perturbation analysi
38 Here,
we describe site-selective, copper-promoted couplings of boro
39 In this review,
we describe speculative ideas and early stage research concer
40 Here
we describe the 'Asgard' superphylum, a group of uncultivated
41 In this report
we describe the appearance of transgene-specific T-cell respo
42 paper of the Series on health, equity, and women's cancers,
we describe the burden of breast and cervical cancer, with an
43 We describe the effect of varying particle size and shape on
44 Here,
we describe the FEP+ method as applied to protein stability c
45 Here
we describe the stabilization of the heaviest 4+ ion of the p
46 Using computational analysis,
we describe the structural and photophysical properties of th
47 We describe the structure and morphology of aggregates formed
48 We describe this method using dulaglutide, a glucagon-like pe
49 Here,
we describe two brothers with hematopoietic and immunologic s
50 We describe two new complementary approaches - stable isotope